Literature DB >> 11163214

Cytoskeletal protein PSTPIP1 directs the PEST-type protein tyrosine phosphatase to the c-Abl kinase to mediate Abl dephosphorylation.

F Cong1, S Spencer, J F Côté, Y Wu, M L Tremblay, L A Lasky, S P Goff.   

Abstract

A search for c-Abl interacting proteins resulted in the recovery of PSTPIP1, originally identified as a binding protein of the PEST-type protein tyrosine phosphatases (PTP). PSTPIP1 was phosphorylated by c-Abl, and growth factor-induced PSTPIP1 phosphorylation was diminished in Abl null fibroblasts. PSTPIP1 was able to bridge c-Abl to the PEST-type PTPs. Several experiments suggest that the PEST-type PTPs negatively regulate c-Abl activity: c-Abl was hyperphosphorylated in PTP-PEST-deficient cells; disruption of the c-Abl-PSTPIP1-PEST-type PTP ternary complex by overexpression of PSTPIP1 mutants increased c-Abl phosphotyrosine content; and PDGF-induced c-Abl kinase activation was prolonged in PTP-PEST-deficient cells. Dephosphorylation of c-Abl by PEST-type PTP represents a novel mechanism by which c-Abl activity is regulated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11163214     DOI: 10.1016/s1097-2765(00)00138-6

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  36 in total

1.  TCR-induced downregulation of protein tyrosine phosphatase PEST augments secondary T cell responses.

Authors:  Yutaka Arimura; Torkel Vang; Lutz Tautz; Scott Williams; Tomas Mustelin
Journal:  Mol Immunol       Date:  2008-05-05       Impact factor: 4.407

2.  Protein kinase G increases antioxidant function in lung microvascular endothelial cells by inhibiting the c-Abl tyrosine kinase.

Authors:  R Scott Stephens; Laura E Servinsky; Otgonchimeg Rentsendorj; Todd M Kolb; Alexander Pfeifer; David B Pearse
Journal:  Am J Physiol Cell Physiol       Date:  2014-01-08       Impact factor: 4.249

3.  Dysregulated neutrophil responses and neutrophil extracellular trap formation and degradation in PAPA syndrome.

Authors:  Pragnesh Mistry; Carmelo Carmona-Rivera; Amanda K Ombrello; Patrycja Hoffmann; Nickie L Seto; Anne Jones; Deborah L Stone; Faiza Naz; Philip Carlucci; Stefania Dell'Orso; Gustavo Gutierrez-Cruz; Hong-Wei Sun; Daniel L Kastner; Ivona Aksentijevich; Mariana J Kaplan
Journal:  Ann Rheum Dis       Date:  2018-08-21       Impact factor: 19.103

4.  c-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesis.

Authors:  Olivia Furstoss; Karel Dorey; Valérie Simon; Daniela Barilà; Giulio Superti-Furga; Serge Roche
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

Review 5.  Linking up at the BAR: Oligomerization and F-BAR protein function.

Authors:  Nathan A McDonald; Kathleen L Gould
Journal:  Cell Cycle       Date:  2016-05-31       Impact factor: 4.534

Review 6.  Signaling networks regulating leukocyte podosome dynamics and function.

Authors:  Athanassios Dovas; Dianne Cox
Journal:  Cell Signal       Date:  2011-02-20       Impact factor: 4.315

7.  Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway.

Authors:  Nitza G Shoham; Michael Centola; Elizabeth Mansfield; Keith M Hull; Geryl Wood; Carol A Wise; Daniel L Kastner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

8.  Essential function of PTP-PEST during mouse embryonic vascularization, mesenchyme formation, neurogenesis and early liver development.

Authors:  Jacinthe Sirois; Jean-François Côté; Alain Charest; Noriko Uetani; Annie Bourdeau; Stephen A Duncan; Eugene Daniels; Michel L Tremblay
Journal:  Mech Dev       Date:  2006-09-01       Impact factor: 1.882

9.  Activation of abl family kinases in solid tumors.

Authors:  Sourik S Ganguly; Rina Plattner
Journal:  Genes Cancer       Date:  2012-05

10.  Pyrin Modulates the Intracellular Distribution of PSTPIP1.

Authors:  Andrea L Waite; Philip Schaner; Neil Richards; Banu Balci-Peynircioglu; Seth L Masters; Susannah D Brydges; Michelle Fox; Arthur Hong; Engin Yilmaz; Daniel L Kastner; Ellis L Reinherz; Deborah L Gumucio
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.